Diabetes drug tested as potential blood thinner
NCT ID NCT06933056
Summary
This early research study aims to see if a medication called sotagliflozin, which is used for diabetes, might also help reduce blood clotting. Researchers will compare its effects on blood platelets to those of several FDA-approved antiplatelet drugs like aspirin. The study involves 20 healthy volunteers who will have their blood tested to measure clotting activity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLATELET FUNCTION AND REACTIVITY TESTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.